1-(2-trifluoromethylphenyl)imidazole has been researched along with Ischemic Attack, Transient in 1 studies
1-(2-trifluoromethylphenyl)imidazole: an inhibitor of neuronal nitric oxide synthase in mouse
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Escott, KJ | 1 |
| Beech, JS | 1 |
| Haga, KK | 1 |
| Williams, SC | 1 |
| Meldrum, BS | 1 |
| Bath, PM | 1 |
1 other study available for 1-(2-trifluoromethylphenyl)imidazole and Ischemic Attack, Transient
| Article | Year |
|---|---|
Cerebroprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluoromethylphenyl) imidazole and 7-nitro indazole, after transient focal cerebral ischemia in the rat.
Topics: Animals; Cell Survival; Enzyme Inhibitors; Imidazoles; Indazoles; Ischemic Attack, Transient; Male; | 1998 |